Monitoring gastric cancer progression with circulating tumour DNA

BACKGROUND: Circulating tumour DNA (ctDNA) is an emerging candidate biomarker for malignancies and may be useful for monitoring the disease status of gastric cancer. METHODS: We performed targeted deep sequencing of plasma cell-free DNA (cfDNA) by massively parallel sequencing in patients with tumou...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamakawa, T, Kukita, Y, Kurokawa, Y, Miyazaki, Y, Takahashi, T, Yamasaki, M, Miyata, H, Nakajima, K, Taniguchi, K, Takiguchi, S, Mori, M, Doki, Y, Kato, K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453461/
https://www.ncbi.nlm.nih.gov/pubmed/25490524
http://dx.doi.org/10.1038/bjc.2014.609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4453461/
https://www.ncbi.nlm.nih.gov/pubmed/25490524
http://dx.doi.org/10.1038/bjc.2014.609

Ejemplares similares